The "milky way" galaxy of HIV-related central nervous system immune reaction syndromes.
Central nervous system
HIV
Immune reconstitution inflammatory syndrome
Immunoglobulins
Progressive multifocal leukoencephalopathy
Punctate pattern
Journal
Journal of neurovirology
ISSN: 1538-2443
Titre abrégé: J Neurovirol
Pays: United States
ID NLM: 9508123
Informations de publication
Date de publication:
12 2019
12 2019
Historique:
received:
13
11
2018
accepted:
24
05
2019
revised:
18
05
2019
pubmed:
20
6
2019
medline:
22
10
2020
entrez:
20
6
2019
Statut:
ppublish
Résumé
The landscape of central nervous system HIV infection is rapidly changing, leading to the recognition of a new constellation of overlapping syndromes and to a better insight for the elder ones. Among these, progressive multifocal leukoencephalopathy (PML) still poses several diagnostic and therapeutic challenges; nevertheless, recent developments in understanding PML in patients with multiple sclerosis may have benefitted HIV-positive patients suffering from PML too. We describe a peculiar case of PML-immune reconstitution inflammatory syndrome (IRIS) presenting a punctate pattern with "milky way" appearance on magnetic resonance imaging. Despite the fact that brain imaging and histopathology remain the mainstays for extricating through the expanding galaxy of HIV-related central nervous system dysimmune syndromes and although punctate pattern has been already well acknowledged as a suggestive finding of PML among patients on natalizumab, this radiological presentation is still poorly recognised in AIDS-related PML cases, leading to possible life-threatening diagnostic delays. This is also the first report about intravenous immunoglobulin treatment in AIDS-related PML-IRIS; the favourable clinical and radiological outcome of our case and the preliminary administrations of intravenous immunoglobulins in natalizumab-associated PML-IRIS from literature support probable benefits also among HIV-positive patients.
Identifiants
pubmed: 31214917
doi: 10.1007/s13365-019-00769-4
pii: 10.1007/s13365-019-00769-4
doi:
Substances chimiques
Immunoglobulins, Intravenous
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
887-892Références
Scand J Infect Dis. 2007;39(6-7):630-4
pubmed: 17577834
J Med Virol. 2009 Apr;81(4):578-81
pubmed: 19235861
Neurology. 2016 Apr 19;86(16):1516-23
pubmed: 27009257
Acta Neuropathol. 2005 Apr;109(4):449-55
pubmed: 15739098
J Neurol Neurosurg Psychiatry. 2013 Oct;84(10):1068-74
pubmed: 23606731
Neuroradiology. 2016 Mar;58(3):221-35
pubmed: 26700824
Brain Pathol. 2013 Sep;23(5):525-33
pubmed: 23347174
J Neurol Neurosurg Psychiatry. 2018 Oct;89(10):1125-1126
pubmed: 29305436
Mol Pathol. 2001 Oct;54(5):354-9
pubmed: 11577180
Antivir Ther. 2016;21(7):633-635
pubmed: 26857363
J Virol. 2011 Jul;85(14):7256-63
pubmed: 21543472
Neurol Neuroimmunol Neuroinflamm. 2017 Jun 14;4(4):e370
pubmed: 28638853
Clin Neurol Neurosurg. 2013 Sep;115(9):1861-3
pubmed: 23535451
Lancet Neurol. 2018 May;17(5):467-480
pubmed: 29656742
Ann Neurol. 2008 May;63(5):662-7
pubmed: 18481293
Clin Infect Dis. 2013 Jul;57(1):101-8
pubmed: 23515205
Neurology. 2009 Apr 28;72(17):1458-64
pubmed: 19129505